Literature DB >> 2832710

Antiviral activity of Chamaecyparis lawsoniana extract: study with herpes simplex virus type 2.

M Debiaggi1, L Pagani, P M Cereda, P Landini, E Romero.   

Abstract

Ethanolic extract of the green part of Chamaecyparis Lawsoniana was tested for antiviral activity and toxicity in tissue culture. All experiments were carried out in confluent human embryo lung fibroblasts. Treatment of fibroblast cells with extracts after viral inoculation was effective in inhibiting the replication of herpes simplex virus type 2 (HSV-2). The critical time for virus inhibition was 4 to 5 h after virus absorption. The antiviral activity was assayed employing the techniques of viral plaque and yield reduction. Toxicity of Chamaecyparis Lawsoniana in uninfected cells was studied as alteration of cell morphology, cellular viability and inhibition of host cell DNA synthesis. Herpes simplex virus inhibition occurred in presence of extract concentration of 0.5 micrograms/ml, whereas concentrations exceeding 5 micrograms/ml and 140 micrograms/ml were found to be cytotoxic when evaluated with inhibition of host DNA synthesis and cellular viability respectively. Results suggest that further investigations concerning the isolation of substances responsible for antiviral activity and an effort to define the mechanisms of action are warranted.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2832710

Source DB:  PubMed          Journal:  Microbiologica        ISSN: 0391-5352


  9 in total

Review 1.  Multi-Omics Approach in the Identification of Potential Therapeutic Biomolecule for COVID-19.

Authors:  Rachana Singh; Pradhyumna Kumar Singh; Rajnish Kumar; Md Tanvir Kabir; Mohammad Amjad Kamal; Abdur Rauf; Ghadeer M Albadrani; Amany A Sayed; Shaker A Mousa; Mohamed M Abdel-Daim; Md Sahab Uddin
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

2.  Potentials of plant-based substance to inhabit and probable cure for the COVID-19.

Authors:  Israt Jahan; Ahmet Onay
Journal:  Turk J Biol       Date:  2020-06-21

3.  Genomics approaches to synthesis plant-based biomolecules for therapeutic applications to combat SARS-CoV-2.

Authors:  Namisha Sharma; Mehanathan Muthamilarasan; Ashish Prasad; Manoj Prasad
Journal:  Genomics       Date:  2020-07-24       Impact factor: 5.736

Review 4.  Licorice (Glycyrrhiza glabra) Extracts-Suitable Pharmacological Interventions for COVID-19? A Review.

Authors:  Joji Abraham; Singarayer Florentine
Journal:  Plants (Basel)       Date:  2021-11-26

5.  NS3/4A helicase inhibitory alkaloids from Aptenia cordifolia as HCV target.

Authors:  Asmaa Abo Elgoud Said; Ahmed H Afifi; Taha F S Ali; Mamdouh Nabil Samy; Usama Ramadan Abdelmohsen; Mostafa A Fouad; Eman Zekry Attia
Journal:  RSC Adv       Date:  2021-10-06       Impact factor: 4.036

6.  A phylogenetic perspective of antiviral species of the genus Artemisia (Asteraceae-Anthemideae): A proposal of anti SARS-CoV-2 (COVID-19) candidate taxa.

Authors:  Adil Hussain
Journal:  J Herb Med       Date:  2022-09-28       Impact factor: 2.542

7.  In Silico Exploration of Phytoconstituents From Phyllanthus emblica and Aegle marmelos as Potential Therapeutics Against SARS-CoV-2 RdRp.

Authors:  Khushboo Pandey; Kiran Bharat Lokhande; K Venkateswara Swamy; Shuchi Nagar; Manjusha Dake
Journal:  Bioinform Biol Insights       Date:  2021-06-24

Review 8.  A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov.

Authors:  Rambod Abiri; Hazandy Abdul-Hamid; Oksana Sytar; Ramin Abiri; Eduardo Bezerra de Almeida; Surender K Sharma; Victor P Bulgakov; Randolph R J Arroo; Sonia Malik
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

Review 9.  Antiviral potentials of medicinal plants.

Authors:  Muhammad Mukhtar; Mohammad Arshad; Mahmood Ahmad; Roger J Pomerantz; Brian Wigdahl; Zahida Parveen
Journal:  Virus Res       Date:  2007-11-05       Impact factor: 3.303

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.